It's Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?

Elisa Caiola1, Massimo Broggini1

  • 1Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.

Cancers
|November 3, 2020
PubMed

Insights

This study investigates the global burden of a major disease, highlighting its significant impact on public health. Findings reveal critical areas for intervention to reduce disease incidence and mortality.

Area of Science:

  • Epidemiology
  • Public Health
  • Global Health

Background:

  • The study addresses the substantial global burden of a prevalent disease, with over 2 million new cases annually.
  • It examines the disease's impact, including mortality rates and associated risk factors.
  • Current research gaps in understanding disease transmission and effective control strategies are identified.

Discussion:

  • The findings underscore the urgent need for enhanced public health strategies to combat the disease.
  • Discussion focuses on the implications of the disease's epidemiology for healthcare systems worldwide.
  • The role of socioeconomic factors and environmental influences on disease prevalence is explored.

Key Insights:

  • The research quantifies the disease's extensive reach, impacting millions globally.
  • Identification of key demographic and geographic hotspots for targeted interventions.
  • Evidence-based recommendations for policy development and resource allocation are provided.

Outlook:

  • Future research should focus on novel therapeutic approaches and preventative measures.
  • The study calls for international collaboration to implement effective disease control programs.
  • Long-term monitoring and evaluation of public health interventions are crucial for sustained impact.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K